0001140361-17-022005.txt : 20170523
0001140361-17-022005.hdr.sgml : 20170523
20170523175019
ACCESSION NUMBER: 0001140361-17-022005
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170519
FILED AS OF DATE: 20170523
DATE AS OF CHANGE: 20170523
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HANGER, INC.
CENTRAL INDEX KEY: 0000722723
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 840904275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
BUSINESS PHONE: 512-777-3800
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
FORMER COMPANY:
FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: SEQUEL CORP
DATE OF NAME CHANGE: 19890814
FORMER COMPANY:
FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC
DATE OF NAME CHANGE: 19860304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Adams Gabrielle B.
CENTRAL INDEX KEY: 0001651089
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10670
FILM NUMBER: 17864875
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE, SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
4
1
doc1.xml
FORM 4
X0306
4
2017-05-19
0
0000722723
HANGER, INC.
HGR
0001651089
Adams Gabrielle B.
10910 DOMAIN DRIVE, SUITE 300
AUSTIN
TX
78758
0
1
0
0
Vice President Accounting
Common Stock
28273
D
Stock Options (right to buy)
12.77
2017-05-19
4
A
0
30938
0
A
2027-05-19
Common Stock
30938
30938
D
Performance Share Units
2017-05-19
4
A
0
12375
0
A
2020-05-19
Common Stock
12375
12375
D
Includes (i) unvested restricted shares which total 7,750 shares of stock from an initial grant of 7,750 shares of restricted stock that begins to vest on March 8, 2018, (ii) unvested restricted shares which total 3,000 shares of stock from an initial grant of 3,000 shares of restricted stock that begins to vest on October 11, 2017, (iii) unvested restricted shares and fully vested shares which total 7,750 shares of stock from an initial grant of 7,750 shares of restricted stock that begins to vest on March 7, 2017, (iv) unvested restricted shares and fully vested shares which total 3,305 shares of stock from an initial grant of 3,305 shares of restricted stock made on November 10, 2015, (v) unvested restricted shares and fully vested shares which total 2,229 shares of stock from an initial grant of 2,229 shares of restricted stock made on September 8, 2015 and [continued in next footnote]
(vi) unvested restricted shares and fully vested shares which total 4,239 shares of stock from an initial grant of 4,239 shares of restricted stock made on March 6, 2015. Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020.
Performance share units ("PSUs") were granted under the Company's Special Equity Plan. Each PSU represents a contingent right to receive one share of common stock if predetermined levels of absolute common stock price compounded annual growth rate are achieved over a three-year performance period ending on the third anniversary of the grant date. The number of PSUs shown in the table represents the maximum number that could be earned; the target number is one-half the maximum number.
Jessica Lochmann Allen, Attorney-in-Fact for Gabrielle B. Adams
2017-05-23